GUFIC BIOSCIENCES
|
GUFIC BIOSCIENCES Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹94 Cr | ₹116 Cr |
| Adjustment | ₹44 Cr | ₹34 Cr |
| Changes In working Capital | ₹7.44 Cr | ₹-130 Cr |
| Cash Flow after changes in Working Capital | ₹145 Cr | ₹20 Cr |
| Cash Flow from Operating Activities | ₹123 Cr | ₹-7.46 Cr |
| Cash Flow from Investing Activities | ₹-71 Cr | ₹-102 Cr |
| Cash Flow from Financing Activities | ₹-37 Cr | ₹82 Cr |
| Net Cash Inflow / Outflow | ₹15 Cr | ₹-27 Cr |
| Opening Cash & Cash Equivalents | ₹1.14 Cr | ₹29 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹16 Cr | ₹1.14 Cr |
Compare Cashflow Statement of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹3,277.3 Cr | -1.8% | -9.8% | -25.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -1.8% |
-9.8% |
-25.4% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses